American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement
U.S. Newswire › December 13, 2007
Linked as:
Summary
To: NATIONAL EDITORS
Contact: Joanna Carr, +1-214-706-1396; Wynette Randolph, +1-214- 706-1173; Carrie Thacker, +1-214-706-1665; Cathy Lewis, +1-214-706- 1324, cathy.lewis@heart.org; Bridgette McNeill, +1-214-706-1135, bridgette.mcneill@heart.org; Karen Astle, +1-214-706-1392, karen.astle@heart.org; Broadcast: Julie Del Barto, +1-214-706-1330; New York City: Darcy Spitz, +1-212-878-5940; Washington: Suzanne Ffolkes, +1-202-785-7929, all of the American Heart Association; Spencer B. King, III, M.D., +1-404-273-3488, spencer.king@piedmont.org; or Sidney C. Smith, Jr., M.D., +1-919- 824-6113, scs@med.unc.edu, both of the Guideline Writing CommitteeSee the full content of this document
Extract
American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement
Long-term treatment after drug-eluting stents is key
DALLAS, Dec. 13 /PRNewswire-USNewswire/ -- Dual antiplatelet therapy is extremely important after implanting a drug-eluting stent to open a blocked coronary artery, according to updated joint Guidelines for Percutaneous Coronary Intervention from the American College of Cardiology, American Heart Association and Society for Cardiovascular Angiography and Interventions. The guidelines also note t...See the full content of this document
Sponsored links
